What is Rejuve Token (RJV)?

Quick Facts

  • Token name: Rejuve Token (RJV)
  • Platform: Rejuve.AI — a decentralized longevity research network
  • Ecosystem: SingularityNET / ASI Alliance spin-off
  • Blockchains: Ethereum, BNB Smart Chain, and Cardano
  • Use case: Membership, health data rewards, and health product access
  • App: Rejuve Longevity App, available on iOS and Android
  • Leadership: CEO Jasmine Smith; Chief AI Scientist Dr. Ben Goertzel

Introduction

Rejuve Token (RJV) is the utility and membership token powering the Rejuve.AI network — a decentralized platform that combines artificial intelligence, blockchain technology, and longevity research. The platform's core mission is to democratize access to healthspan-extending therapies by putting health data ownership back in the hands of individuals.

Unlike traditional wellness platforms that silo user data, Rejuve.AI rewards participants for voluntarily sharing their health information, then uses that data to fuel cutting-edge longevity research.

History & Background

Rejuve.AI began as one of SingularityNET's earliest AI research initiatives before spinning off as a standalone project within the broader SingularityNET ecosystem. Its Token Generation Event launched in 2023, with RJV initially minted on both the Ethereum and Cardano blockchains.

The project was co-founded under the guidance of Dr. Ben Goertzel, a pioneer in Artificial General Intelligence (AGI) and CEO of SingularityNET, and Dr. Deborah Duong, a leading researcher in AI applied to health sciences.

How Rejuve Token Works

Users download the Rejuve Longevity App and contribute health data — from surveys and lab results to wearable device readings. In return, they earn RJV tokens. The platform's AI, which incorporates over 300 biomarkers, then generates personalized biological age estimates and longevity recommendations.

RJV token holders can also vote on how their data is used within the network, giving the community meaningful governance over research priorities.

Tokenomics

RJV is designed as a membership and reward token with a clear utility focus. Tokens are earned through data contributions and redeemable for health-enhancing products and services — including supplements, wearables, medical tests, longevity therapies, and travel. The model ensures that every contributor to the network receives proportional compensation for their participation, aligning incentives across individuals, researchers, clinics, and AI developers.

Circulating supply ? 515.27 million RJV
Reserved supply ? 0 RJV
Burned
0x0000000000000000000000000000000000000001
0 RJV
Total supply ? 515.27 million RJV
Max supply ? 1.00 billion RJV
Updated 5h ago

Ecosystem & Use Cases

RJV tokens unlock access to a growing partner network that includes companies such as Garmin, GlycanAge, TruDiagnostics, Lifelength, and Travala. By creating a Data NFT (dNFT), users gain formal membership to the Rejuve Network and access to additional rewards.

AI scientists and developers can also contribute models through the Generative Cooperative Network (GCN), earning RJV rewards for helping simulate human biology and develop new aging therapies.

Team, Governance & Community

Rejuve.AI is led by CEO Jasmine Smith and operates within the ASI Alliance alongside SingularityNET. Dr. Ben Goertzel serves as Chief AI Scientist, and Dr. Deborah Duong as CTO. The community of RJV holders participates in governance by voting on data usage policies, embodying the platform's decentralized science (DeSci) ethos.

Advantages

  • Data sovereignty: Users own and monetize their personal health data
  • Real utility: Tokens are redeemable for tangible health products and services
  • Strong ecosystem: Backed by SingularityNET and the ASI Alliance
  • AI-driven insights: Over 300 biomarkers power personalized longevity analysis
  • Community governance: Token holders vote on data and research decisions

Risks & Challenges

  • Regulatory uncertainty: Health data platforms face evolving privacy regulations globally
  • Adoption dependency: Network value is closely tied to user and partner growth
  • Research complexity: Translating data into proven longevity therapies is a long-horizon challenge
  • Market competition: The digital health and DeSci space is becoming increasingly competitive

Long-Term Vision

Rejuve.AI's long-term ambition is to build a global, decentralized research database that accelerates the discovery of therapies capable of extending human healthspan. By aggregating data from millions of individuals worldwide and applying advanced AI tools — including OpenCog Hyperon and Bayesian reasoning engines — the platform aims to make longevity science accessible and affordable for everyone, not just the privileged few.

Frequently Asked Questions

RJV is the utility and membership token of the Rejuve.AI network. Users earn it by sharing health data and can redeem it for supplements, medical tests, wearables, and longevity services through the platform's partner network.

Users earn RJV by contributing health data through the Rejuve Longevity App. This includes completing health surveys, connecting wearable devices, and submitting lab test results.

RJV was initially minted on the Ethereum and Cardano blockchains and is also available on BNB Smart Chain. This multi-chain approach broadens accessibility for different user communities.

Rejuve.AI originated as one of SingularityNET's earliest AI research initiatives and later spun off as a standalone project within the broader ecosystem. It remains part of the ASI Alliance and benefits from SingularityNET's AI infrastructure and developer community.

Yes. RJV token holders can vote on how their data is used within the network, giving the community a direct role in governance and research direction.

A Data NFT (dNFT) grants users formal membership to the Rejuve Network. Creating one unlocks additional rewards and benefits within the ecosystem.

Rejuve.AI is led by CEO Jasmine Smith. Dr. Ben Goertzel, CEO of SingularityNET, serves as Chief AI Scientist, while Dr. Deborah Duong, a leading AGI researcher, serves as CTO.

Rejuve.AI follows the Decentralized Science (DeSci) model by giving individuals control over their own health data and compensating them fairly for its use in research. This contrasts with traditional systems where large companies silo and monetize user data without sharing the value.